Literature DB >> 8006369

Holocarboxylase synthetase deficiency: a treatable metabolic disorder masquerading as cerebral palsy.

M Livne1, K M Gibson, N Amir, G Eshel, O N Elpeleg.   

Abstract

A 20-month-old boy of Jewish-Turkish origin presented with severe metabolic acidosis. He was born prematurely and had bacteremia during the neonatal period. Scaly skin eruption, developmental delay, generalized muscular hypertonia, and mild ventriculomegaly were noted during the 1st year. Holocarboxylase synthetase deficiency was diagnosed, and biotin and carnitine were administered. The skin rash and the organic aciduria resolved within several days, and at 30 months, his psychomotor development was appropriate for age. Metabolic evaluation should be performed in patients with combined neurologic and dermatologic symptoms even when medical history suggests a nonmetabolic etiology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006369     DOI: 10.1177/088307389400900213

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

Review 1.  Cerebral palsy: not always what it seems.

Authors:  R Gupta; R E Appleton
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

Review 2.  Antenatal and postnatal radiologic diagnosis of holocarboxylase synthetase deficiency: a systematic review.

Authors:  Sahan P Semasinghe Bandaralage; Soheil Farnaghi; Joel M Dulhunty; Alka Kothari
Journal:  Pediatr Radiol       Date:  2016-01-11

3.  Holocarboxylase synthetase deficiency: report of a case with onset in late infancy.

Authors:  E Touma; T Suormala; E R Baumgartner; B Gerbaka; H Ogier de Baulny; J Loiselet
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

4.  Late-onset holocarboxylase synthetase deficiency.

Authors:  K M Gibson; M J Bennett; W L Nyhan; C E Mize
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 5.  Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

Authors:  Hélio A G Teive; Carlos Henrique F Camargo; Eduardo R Pereira; Léo Coutinho; Renato P Munhoz
Journal:  Neurogenetics       Date:  2022-04-09       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.